ENGERIX-B: cost and payments to doctors
What Medicare Part D paid pharmacies for ENGERIX-B, and the payments that named it as the associated drug or biological under the Sunshine Act for program years 2019–2025.
Part D cost for ENGERIX-B formulations
Medicare reports ENGERIX-B under its specific formulations, which are priced separately.
- engerix b adult$82per 30-day fill · 454 claims · Hepatitis B Virus Vaccine/Pf
Paid to pharmacies by Part D plans and patients — not your cost, and not paid to the prescriber. Is this wrong?
Was your doctor paid by GSK?
GSK reported the most payments naming ENGERIX-B. Search your clinician to see whether they are among them — and what else they were paid for.
Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.
- Total reported
- $47K
- Providers
- 410
- Transactions
- 461
- Average per transaction
- $101
The per-transaction average — $101 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 410 providers the average total is $114, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| GSK | $46,713 | 100.0% |
Other products from GSK
The company that reported the most payments naming ENGERIX-B also reports against these.